Treating resistant hypertension now and in the future

Yusuke Sata, Jianzhong Xu, Dagmara Hering, Markus Schlaich

Research output: Contribution to journalShort SurveyOtherpeer-review


Treatment of resistant hypertension is a priority because patients with nonoptimal blood pressure are at high risk for major cardiovascular events. Pharmacological advances include the use of aldosterone antagonists and the development of several new strategies. Device-based therapies such as catheter-based renal denervation and electrical stimulation of baroreceptors are showing promising results.

Original languageEnglish
Pages (from-to)20-27
Number of pages8
JournalMedicine Today
Issue number1
Publication statusPublished - Jan 2013
Externally publishedYes

Cite this